ArticleInflammopharmacology2025
Statins could improve short-term prognosis in patients with traumatic brain injury: a propensity-matched cohort study.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesTo investigate whether the use of statins could improve the short-term prognosis of traumatic brain injury (TBI) patients and explore the relationship between the initiation time and duration of post-traumatic statins treatment and short-term prognosis.
methodsTBI patients in the MIMIC IV database were divided into a statin group and a control group. A comparison was made between them in terms of short-term prognosis, including ICU mortality, in-hospital mortality, 28-day mortality, and 90-day mortality. Three subgroup analyses were conducted in this study. Propensity score matching (PSM) method was employed to balance the baseline characteristics. Further stratification based on statin treatment initiation time and duration resulted in four groups.
resultsA total of 1124 eligible TBI patients were included in this study. Before PSM, there were no significant differences between the two groups in terms of the four indexes. After PSM, the statin group showed significantly lower ICU mortality, in-hospital mortality, 28-day mortality, and 90-day mortality compared to the control group. Similarly, after conducting PSM for the three subgroup analyses, similar results were obtained for the GCS < 8 and age greater than 65 years subgroups. In the subgroup analysis of the cohort aged 65 years or under, there were no significant differences in the four metrics between the two groups. The analysis found no discernible correlation between the initiation time and duration of statin treatment and TBI patient prognosis.
conclusionPost-traumatic use of statins can improve the short-term prognosis of TBI patients. In comparison to patients aged ≤ 65 years, TBI patients aged > 65 years who use statin drugs experience significantly better short-term prognosis. The correlation between the initiation time and duration of statin treatment and the prognosis of TBI patients warrants further investigation.
Indexed as
Identifiers
40549314What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.